Nabil Rastani is the Dods Political Consultant focusing on Life Sciences, Public Health and International Trade. Prior to working at Dods, Nabil worked at global pharmaceutical firm Lilly UK in its Public Affairs Department and the International Criminal Court in the Hague. He holds a first class honours degree in International Politics
For the first time in 40 years, the UK will forge its own path as an independent trading nation. This will bring with it a plethora of new opportunities and challenges, writes Dods Monitoring's Nabil Rastani.
A potent tonic of trade wars, protectionist barriers and populist actors has led to the retreat of globalisation. This could have significant ramifications for the life sciences sector, Dods Monitoring's Nabil Rastani writes.
Any new tariffs could impact the production of drugs, Dods Monitoring's Nabil Rastani writes.
In a post-Brexit world, the Government is seeking to forge a new bilateral trade agreement with the US. But this could have wide-ranging implications for the UK’s life sciences sector, as Nabil Rastani writes.
The UK’s life sciences sector is a thriving hub of research and innovation but with a loss of access to international talent, the vitality of the sector is at stake, writes Nabil Rastani.